Neil W Gibson's Net Worth

$2.25 Million

Estimate Recalculated Jul 1, 2024 05:31AM EST

Who is Neil W Gibson?

Neil W Gibson has an estimated net worth of $2.25 Million. This is based on reported shares across multiple companies, which include Instil Bio, Inc., Shattuck Labs, Inc., TCR2 THERAPEUTICS INC., and Regulus Therapeutics Inc..

SEC CIK

Neil W Gibson's CIK is 0001555918

Past Insider Trading and Trends

2014 was Neil W Gibson's most active year for acquiring shares with 17 total transactions. Neil W Gibson's most active month to acquire stocks was the month of November. 2014 was Neil W Gibson's most active year for disposing of shares, totalling 34 transactions. Neil W Gibson's most active month to dispose stocks was the month of December. 2013 saw Neil W Gibson paying a total of $87,000.00 for 200,000 shares, this is the most they've acquired in one year. In 2015 Neil W Gibson cashed out on 80,000 shares for a total of $1,444,304.42, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Instil Bio, Inc. (TIL) Snapshot price: $11.5599

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
May 20
Form 4
—
0
—
—
0
Mar 18
Form 3
—
0
—
—
0
No matching records found

Shattuck Labs, Inc. (STTK) Snapshot price: $9.635

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
May 26
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jun 19
Form 4
—
0
—
—
0
Dec 22
Form 3
—
0
—
—
0
No matching records found

TCR2 THERAPEUTICS INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Dec 9
Form 4
—
0
—
—
0
Dec 9
Form 4
—
0
—
—
0
Dec 10
Form 4
-100.00%
-706.35K
$6.59
-$525,187.62
0
Nov 7 - Mar 20
Form 4
—
0
—
—
0
Dec 19
Form 4
—
0
—
—
0
Apr 11
Form 4
∞
706.35K
—
—
706.35K
Feb 19
Form 3
—
0
—
—
0
No matching records found

Regulus Therapeutics Inc. (RGLS) Snapshot price: $1.4

Chief Scientific Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-80.00K
$18.05
-$1,444,304.42
0
Scheduled
Jan 28
Form 4
—
0
—
—
0
Dec 2
Form 4
—
0
$10.52
-$43,895.00
80K
Scheduled
Nov 28
Form 4
—
0
$10.51
-$43,884.00
80K
Scheduled
Oct 29
Form 4
—
0
$8.09
-$41,902.08
80K
Scheduled
Oct 22
Form 4
—
0
—
—
0
Oct 20
Form 4
—
0
$4.88
-$26,318.50
80K
Scheduled
Sep 11 - Sep 12
Form 4
—
0
$4.92
-$15,910.00
80K
Scheduled
Jul 1
Form 4
—
0
$4.90
-$31,527.00
80K
Scheduled
Jun 17
Form 4/A
—
0
—
—
0
Apr 9
Form 4/A
—
0
—
—
0
Mar 6
Form 4
—
0
$4.93
-$15,921.25
80K
Scheduled
Apr 9
Form 4
—
0
$6.56
-$24,078.50
80K
Scheduled
Mar 6
Form 4
+60.00%
30K
$5.06
-$64,056.00
80K
Scheduled
Feb 5 - Feb 6
Form 4
—
0
$5.38
-$24,004.26
50K
Scheduled
Jan 21
Form 4
—
0
$5.16
-$26,787.41
50K
Scheduled
Jan 17
Form 4
—
0
$4.89
-$6,922.96
50K
Scheduled
Jan 16
Form 4
—
0
—
—
0
Dec 12
Form 4
∞
50K
$1.74
$87,000.00
50K
Feb 4
Form 4
—
0
—
—
0
Dec 11
Form 3
—
0
—
—
0
No matching records found